Kyowa Kirin Co., Ltd.

General ticker "KYKOF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $8.2B (TTM average)

Kyowa Kirin Co., Ltd. follows the US Stock Market performance with the rate: 26.7%.

Estimated limits based on current volatility of 2.5%: low 15.80$, high 16.60$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-06-30, amount 0.21$ (Y1.27%)
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [10.80$, 18.39$]
  • 2025-12-31 to 2026-12-31 estimated range: [11.55$, 19.27$]

Financial Metrics affecting the KYKOF estimates:

  • Positive: with PPE of 20.1 at the end of fiscal year the price was very low
  • Positive: 7.86 < Operating profit margin, % of 18.54
  • Negative: Investing cash flow per share per price, % of -11.39 <= -4.48
  • Positive: 5.52 < Industry operating cash flow per share per price (median), % of 8.11
  • Positive: Shareholder equity ratio, % of 79.71 > 63.39
  • Negative: 0.01 < Interest expense per share per price, % of 0.60
  • Negative: Operating cash flow per share per price, % of 5.43 <= 6.82
  • Positive: Industry earnings per price (median), % of 5.67 > 4.43

Similar symbols

Short-term KYKOF quotes

Long-term KYKOF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue ¥442,233.00MM ¥495,558.00MM
Operating Expenses ¥355,794.00MM ¥403,692.00MM
Operating Income ¥86,439.00MM ¥91,866.00MM
Non-Operating Income ¥10,807.00MM ¥-8,413.00MM
Interest Expense ¥190.00MM ¥7,538.00MM
R&D Expense ¥81,509.00MM ¥103,544.00MM
Income(Loss) ¥97,246.00MM ¥83,453.00MM
Taxes ¥16,058.00MM ¥0.00MM
Profit(Loss)* ¥81,188.00MM ¥59,870.00MM
Stockholders Equity ¥836,418.00MM ¥850,811.00MM
Inventory ¥71,363.00MM ¥72,933.00MM
Assets ¥1,025,942.00MM ¥1,067,363.00MM
Operating Cash Flow ¥115,551.00MM ¥67,884.00MM
Capital expenditure ¥32,852.00MM ¥105,268.00MM
Investing Cash Flow ¥-20,382.00MM ¥-142,389.00MM
Financing Cash Flow ¥-32,535.00MM ¥-84,697.00MM
Earnings Per Share** ¥151.01 ¥113.06

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.